Advancing
Therapeutic Discovery
Pioneering early-stage discovery of therapeutics for infectious and priority health conditions through target validation and candidate optimization.
Program Overview
This program is dedicated to identifying and characterizing small molecules and peptide-based therapeutics with potential clinical relevance.
Research activities emphasize target validation, molecular interaction analysis, and candidate optimization within a translational research framework designed to move discoveries from the lab to the clinic.
Precision Molecular Engineering
Our team employs advanced in silico modeling and molecular docking to predict interactions before they occur in the lab. This computational-first approach accelerates discovery and reduces development time.
- In silico molecular modeling & dynamics
- High-throughput molecular docking
- Biochemical evaluation & assay development
- Structural biology & crystallography
Strategic Focus Areas
Addressing critical global health challenges through targeted innovation.
Infectious Diseases
Peptide-based therapeutics targeting resistant pathogens and emerging viral threats.
Structure-Guided Design
Using atomic-level structural data to optimize drug-target fit and specificity.
Computational Screening
AI-driven analysis of vast chemical libraries to identify hit compounds.
Candidate Optimization
Refining early-stage molecules for improved stability, potency, and safety.
Integrated Development Approach
Candidate compounds are assessed through an integrated pipeline that combines computational prediction with laboratory-based validation.
Prediction
Computational algorithms predict molecular behavior.
Validation
Wet-lab assays confirm binding and activity.
Optimization
Structure-activity relationships guide refinement.
Collaboration & Future Direction
The program actively supports collaboration with academic institutions, public health organizations, and industry partners to advance promising candidates toward preclinical development.
Global Biomedical Impact
"This work contributes to the development of innovative therapeutic solutions and strengthens early drug discovery capacity within the regional and global biomedical research ecosystem."